AEHR Stock Surges As Bold FY27 Guidance Electrifies Traders

Aehr Test Systems stocks have been trading up by 22.93 percent following strong demand signals for its semiconductor test solutions.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading AEHR

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Fiscal Q4 revenue grew 33% year over year to $18.8M, with AEHR swinging from a loss to $0.11 EPS, well ahead of flat-to-negative expectations.
Management’s fiscal 2027 outlook calls for $130–$150M in revenue and 18%–22% net margins, dramatically above roughly $85M Street expectations.
Record Q4 bookings of $60.7M, an effective backlog near $100.6M, and $116.5M in cash strengthen AEHR’s balance sheet and growth visibility.
New silicon carbide burn-in orders above $8M tied to Chinese EV programs and a top-two global automaker deepen AEHR’s foothold in next-gen EV platforms.
A follow-on FOX-XP order from a lead silicon photonics customer links AEHR directly to booming AI optical interconnect and hyperscale data center demand.

Live Update At 12:32:58 EDT: On Wednesday, July 15, 2026 Aehr Test Systems stock [NASDAQ: AEHR] is trending up by 22.93%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

AEHR has shifted from a sleepy test-equipment name into a high-beta trader favorite. The latest quarter shows why. Aehr Test Systems delivered fiscal Q4 revenue of $18.8M, up 33% year over year, and turned a prior-year loss into $0.11 in EPS. Analysts were looking for roughly breakeven to a slight loss, so this is a clean earnings beat, especially on the bottom line.

On the chart, AEHR has been a wild ride. The stock ran from a close of 69.96 on 2026/07/02 to highs above 116.28 on 2026/06/22 before pulling back. More recently, it closed at 72.01 on 2026/07/14, then ripped intraday to 110.2 the next day before fading to 88.52. That kind of range compresses weeks of action into hours.

Intraday, AEHR’s 5‑minute candles show a classic earnings squeeze-and-fade: a spike off the open to 110.2, heavy selling down through the low 90s, and then choppy volume as traders battled over direction. For active trading, this is prime territory—big liquidity, big range, and clear levels to trade against.

More Breaking News

Fundamentally, AEHR’s high price-to-sales ratio near 59.5 and price-to-book above 19 tell traders the market is already paying up for growth. That makes execution on this new guidance critical.

Why Traders Are Watching AEHR So Closely

AEHR has the story traders love: real numbers, big guidance, and clear secular themes. Aehr Test Systems reported record quarterly bookings of $60.7M and built an effective backlog around $100.6M, while sitting on $116.5M in cash after an equity raise. For a company doing under $20M in quarterly revenue, that is serious firepower and visibility.

The standout piece is guidance. Management of Aehr Test Systems is calling for fiscal 2027 revenue of $130–$150M, 160%–200% growth, with 18%–22% non-GAAP net margins. Street consensus was closer to $85M. That gap is what re-prices stocks. Traders watching AEHR see a management team effectively planting a flag and saying: demand in AI, silicon photonics, and power semis is strong enough to support a major ramp.

Orders back that up. AEHR booked over $8M in new silicon carbide wafer-level burn-in deals, including a big follow-on from its lead SiC customer expanding EV programs in China, plus a qualification order from one of the world’s top two automakers for next-gen EVs. At the same time, Aehr Test Systems locked in a follow-on FOX-XP system order from its lead silicon photonics customer to support AI optical interconnects and hyperscale data centers.

For traders, these aren’t just product wins. They are clues that AEHR is plugged right into two of the hottest themes in the market: EV adoption and AI infrastructure. That combination, plus recent single‑day swings of +14.6% and -15.5%, explains why AEHR has become a go‑to momentum ticker on watchlists.

Conclusion

AEHR is now trading like a story stock backed by hard numbers. Aehr Test Systems has moved from losses to profitability, grown quarterly revenue 33%, and lined up a backlog that nearly equals a full prior-year revenue run rate. Its fiscal 2027 guide of $130–$150M versus roughly $85M consensus sends a clear message that management expects demand in AI processors, silicon photonics, and power semiconductors to accelerate.

But traders still have to respect the risk. AEHR carries rich valuation metrics and shows huge daily swings, with recent sharp rallies and selloffs reminding everyone that sentiment can flip fast. New silicon carbide and silicon photonics orders strengthen the bull case, yet the company must execute across EV and AI cycles to justify its premium.

For active traders, the setup in AEHR is straightforward: track the key levels from this post-earnings spike, watch how price reacts as new orders hit the tape, and stay nimble. As Tim Sykes likes to say, “The market rewards prepared traders, not hopeful gamblers.” As Tim Bohen, lead trainer with StocksToTrade says, “Time and experience have taught me that missed opportunities are part of the game. There’s always another setup around the corner.”. AEHR gives plenty of opportunity—but only for those who manage risk and cut losses quickly.

This coverage is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!